STB
EW icon

S&T Bank’s Edwards Lifesciences EW Stock Holding History

S&T Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6K Hold
117
– – ﹤0.01% 293
2026
Q1 		$9.37K Buy
117
+46
+65% +$3.79K ﹤0.01% 294
2025
Q4 		$6.05K Sell
71
-7
-9% -$574 ﹤0.01% 286
2025
Q3 		$6.07K Buy
78
+18
+30% +$1.41K ﹤0.01% 299
2025
Q2 		$4.69K Buy
60
+7
+13% +$522 ﹤0.01% 295
2025
Q1 		$3.84K Buy
+53
New +$3.79K ﹤0.01% 278

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

S&T Bank's EW Position: Q2 2026 in Review

S&T Bank held its Edwards Lifesciences (EW) position steady in Q2 2026 at 117 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #293.

S&T Bank first reported a position in EW in Q1 2025 and has held it in 6 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • S&T Bank held 117 shares of Edwards Lifesciences worth $10.6K as of Q2 2026.
  • S&T Bank left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of S&T Bank's portfolio in Q2 2026, its #293 holding.
  • S&T Bank first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 6 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.